McKesson has a total of 954 patents globally, out of which 504 have been granted. Of these 954 patents, more than 30% patents are active. United States of America is where McKesson has filed the maximum number of patents, followed by Japan and Europe, it has generated an annual revenue of $58.5 billion in the year 2020. Parallelly, United States of America seems to be the main focused R&D center and is also the origin country of McKesson.
McKesson was founded in the year 1833 by Franz Ludwig Gehe, Charles Olcott, and John McKesson. Company is doing business in pharmaceuticals and providing health information technology, medical supplies, and care management tools. As of January 2022, McKesson has a market cap of $37.95 Billion.
Do read about some of the most popular patents of McKesson which have been covered by us in this article and also you can find McKesson’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over McKesson’s patent portfolio.
How many patents does McKesson have?
McKesson has a total of 954 patents globally. These patents belong to 514 unique patent families. Out of 954 patents, 295 patents are active.
How many McKesson patents are Alive/Dead?
How Many Patents did McKesson File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||McKesson Applications Filed||McKesson Patents Granted|
How Many Patents did McKesson File in Different Countries?
Countries in which McKesson Filed Patents
|United States Of America||257|
|Hong Kong (S.A.R.)||23|
Where are Research Centers of McKesson Patents Located?
10 Best McKesson Patents
US7111780B2 is the most popular patent in the McKesson portfolio. It has received 213 citations so far from companies like Omnicare, Walgreen and Cardinal Health 303.
Below is the list of 10 most cited patents of McKesson:
|Publication Number||Citation Count|
Which Companies are using McKesson Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the McKesson patent portfolio are IBM, Cerner, and ELC Management.
List of the top forward citing Companies –
|Company||Number of Patents|
|Procter & Gamble||6|
|Express Scripts Strategic Development||6|
|Medimpact Healthcare Systems||4|
Count of 102 and 103 Type Rejections based on McKesson Patents
Top McKesson Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of McKesson US Patent Applications were Granted?
McKesson (Excluding its subsidiaries) has filed 612 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 390 have been granted leading to a grant rate of 66.21%.
Below are the key stats of McKesson patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for McKesson?
|Law Firm||Total Application||Success Rate|
|Mckesson Corporation And Alston & Bird Llp||190||41.85%|
|Eversheds Sutherland Us Llp Mck||53||62.26%|
|Alston & Bird Llp||44||47.62%|
|Change Healthcare Llc And Alston & Bird Llp||43||48.84%|
|Medley Behrens & Lewis Llc||30||93.33%|
|Myers Bigel P A||28||92.00%|
|Change Healthcare Holdings Llc||19||94.74%|
|Ballard Spahr Llp For Mckesson||17||87.50%|
|Ballard Spahr Llp||15||100.00%|
|Clark Hill Plc||7||85.71%|
The seed of revolutionary healthcare innovation must germinate someplace, and the most fertile ground is an innovator’s local community, which McKennson is pursuing.
The goal is to foster the development of innovative ideas that will benefit the local healthcare ecosystem by broadening perspectives, challenging and redefining objectives, and catalysing the creation of new approaches. McKennson is striving to uncover opportunities for transformative innovation and to give participants a new framework for thinking about practical solutions that can improve the health of their enterprises and the community as a whole.
The second step in the change was to build an online site for over-the-counter (OTC) items including shampoos, lotions, and ointments, which allows McKesson’s clients to quickly and easily replace stock. When a shelf item is running short, pharmacists can now scan one of the products using a barcode scanner and choose from a list of ten possibilities to reorder the necessary amount.
These new digital capabilities complement McKesson’s transition to a cloud CRM system, which has given the company a single picture of the client and improved service at its call centres.
The future therefore requires a mindset transformation too. “It all comes down to organizational change and thinking about how the next generation of employees is going to use this new technology to take the business forward. And that’s the really exciting part”, said head of B2B for EMEA and UK CIO at global healthcare and pharmacy services giant McKesson.
EXCLUSIVE INSIGHTS COMING SOON!
What are McKesson key innovation segments?
What Technologies are Covered by McKesson?
The chart below distributes patents filed by McKesson in different countries on the basis of the technology protected in patents. It also represents the markets where McKesson thinks it’s important to protect particular technology inventions.
R&D Focus: How McKesson search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by McKesson?